Mini Review
Published on 19 Oct 2022
Neuroprotective and anti-epileptic potentials of genus Artemisia L.
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1021501
- 7,458 views
- 9 citations
Type at least 3 characters
2,453 articles
Review
Published on 19 Oct 2022
The therapeutic potential of triptolide and celastrol in neurological diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1024955
- 6,545 views
- 22 citations
Editorial
Published on 19 Oct 2022
Editorial: Neurodegeneration, cell signaling and neuroreparative strategies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1059923
- 1,143 views
- 1 citation
Original Research
Published on 18 Oct 2022
The research landscape of ferroptosis in the brain: A bibliometric analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1014550
- 3,320 views
- 5 citations
Mini Review
Published on 14 Oct 2022
Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.948412
- 3,752 views
- 6 citations
Original Research
Published on 14 Oct 2022
Neuroprotective effect of phospholipase A2 from Malaysian Naja sumatrana venom against H2O2-induced cell damage and apoptosis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.935418
- 3,061 views
- 10 citations
Review
Published on 13 Oct 2022
Terpenoid natural products exert neuroprotection via the PI3K/Akt pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1036506
- 4,073 views
- 17 citations
Original Research
Published on 13 Oct 2022
A monoamine oxidase B inhibitor ethyl ferulate suppresses microglia-mediated neuroinflammation and alleviates ischemic brain injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1004215
- 3,948 views
- 12 citations
Original Research
Published on 12 Oct 2022
Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.906717
- 6,873 views
- 7 citations
Original Research
Published on 12 Oct 2022
Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.944376
- 6,122 views
- 21 citations
Review
Published on 12 Oct 2022
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1005702
- 6,321 views
- 20 citations
Review
Published on 12 Oct 2022
Advances in the roles and mechanisms of lignans against Alzheimer’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.960112
- 4,850 views
- 16 citations
Review
Published on 11 Oct 2022
Traditional Chinese medicine promotes the control and treatment of dementia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1015966
- 11,842 views
- 11 citations
Original Research
Published on 11 Oct 2022
Voltage dependence of the cannabinoid CB1 receptor
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1022275
- 2,159 views
- 7 citations
Original Research
Published on 10 Oct 2022
Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptor
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1012622
- 3,755 views
- 4 citations
Original Research
Published on 07 Oct 2022
Effectiveness of perampanel in the treatment of pediatric patients with focal epilepsy and ESES: A single-center retrospective study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1026836
- 4,104 views
- 10 citations